SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-028146
Filing Date
2022-10-11
Accepted
2022-10-11 17:05:14
Documents
13
Period of Report
2022-10-07
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43271
  Complete submission text file 0001493152-22-028146.txt   263545

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20221007.xsd EX-101.SCH 3950
3 XBRL DEFINITION FILE hrow-20221007_def.xml EX-101.DEF 27023
4 XBRL LABEL FILE hrow-20221007_lab.xml EX-101.LAB 37280
5 XBRL PRESENTATION FILE hrow-20221007_pre.xml EX-101.PRE 25644
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5542
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 221304693
SIC: 2834 Pharmaceutical Preparations